睿智医药子公司拟5800万元参投产业基金 重点投资创新药

Core Viewpoint - The company, through its wholly-owned subsidiary Beihai Ruizhi, has entered into a partnership to establish a new investment fund focused on the healthcare industry, particularly innovative drugs and medical devices, with a total committed capital of 200 million yuan [1] Group 1: Investment Details - The partnership involves Beihai Ruizhi contributing 58 million yuan, representing 29% of the total committed capital [1] - The fund aims to invest primarily in innovative drugs, leveraging the expertise and capital advantages of professional investment institutions [1] Group 2: Strategic Implications - The investment is expected to enhance the company's capital operation capabilities and strengthen its competitiveness in the innovative drug sector [1] - The collaboration with professional investment institutions is anticipated to improve risk control and generate investment returns for the company [1]